Embryonic ApS: Financial statements 2023
CVR: 39913739
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Embryonic ApS (CVR 39913739) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK 50,000. The solvency ratio was 50%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 50,000
- Total Assets
- DKK 100,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | 0 | 0 | 50 t. | - |
| 2022 | - | - | 0 | 50 t. | - |
| 2021 | - | - | 0 | 70 t. | - |
| 2020 | - | - | 0 | 50 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Embryonic ApS has published its annual report for 2022. The net result was DKK 0.
About Embryonic ApS
Embryonic ApS is a Danish company of the type Anpartsselskab based in Hesselager, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jens Brandt Nellegaard. The board consists of Jens Brandt Nellegaard (chair). The company is owned by Jens Brandt Nellegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 50,000.